ABSTRACT Background: Although a higher consumption of alcohol, which is a methyl-group antagonist, was previously associated with colorectal cancer risk, mechanisms remain poorly understood. Objective: We hypothesized that excess alcohol consumption might increase risk of colorectal carcinoma with hypomethylation of insulinlike growth factor 2 (IGF2) differentially methylated region-0 (DMR0), which was previously associated with a worse prognosis. Design: With the use of a molecular pathologic epidemiology database in 2 prospective cohort studies, the Nurses' Health Study and Health Professionals Follow-up Study, we examined the association between alcohol intake and incident colorectal cancer according to the tumor methylation level of IGF2 DMR0. Duplication-method Cox proportional cause-specific hazards regression for competing risk data were used to compute HRs and 95% CIs. In addition, we investigated intakes of vitamin B-6, vitamin B-12, methionine, and folate as exposures. Results: During 3,206,985 person-years of follow-up, we identified 993 rectal and colon cancer cases with an available tumor DNA methylation status. Compared with no alcohol consumption, the consumption of $15 g alcohol/d was associated with elevated risk of colorectal cancer with lower levels of IGF2 DMR0 methylation [within the first and second quartiles: HRs of 1.55 (95% CI: 1.08, 2.24) and 2.11 (95% CI: 1.44, 3.07), respectively]. By contrast, alcohol consumption was not associated with cancer with higher levels of IGF2 DMR0 methylation. The association between alcohol and cancer risk differed significantly by IGF2 DMR0 methylation level (P-heterogeneity = 0.006). The association of vitamin B-6, vitamin B-12, and folate intakes with cancer risk did not significantly differ according to IGF2 DMR0 methylation level (P-heterogeneity . 0.2). Conclusions: Higher alcohol consumption was associated with risk of colorectal cancer with IGF2 DMR0 hypomethylation but not risk of cancer with high-level IGF2 DMR0 methylation. The association between alcohol intake and colorectal cancer risk may differ by tumor epigenetic features.
INTRODUCTION
DNA methylation plays a critical role as an epigenetic mechanism in the control of gene expression. Loss of imprinting (LOI) 7 of the insulin-like growth factor 2 (IGF2) gene is a common epigenetic aberration in various human cancers including colorectal, lung, bladder, esophageal, and prostate cancers (1) (2) (3) (4) (5) (6) . LOI of IGF2 was previously associated with increased risks of colorectal cancer (7) and adenoma (8) as well as a poor prognosis of colorectal cancer (9) . IGF2 is located in chromosome 11p15 and expressed predominately from the paternal allele. The IGF2 gene encodes the IGF2 protein, which has antiapoptotic and mitogenic functions and plays a role in cell proliferation (10, 11) . DNA methylation is an important epigenetic mechanism that plays a major role in gene regulation and imprinting (12, 13) . Hypomethylation at the differentially methylated region-0 (DMR0) has been related with LOI of IGF2 in colorectal cancer (6, 7) , which leads to IGF2 upregulation. The measurement of IGF2 DMR0 methylation is a well-established surrogate for IGF2 LOI (8, 14) . Moreover, the methylation level of IGF2 DMR0 is associated with the prognosis in colorectal cancer patients, indicating the clinical usefulness of this marker (9) .
Alcohol antagonizes one-carbon metabolism, which is essential for DNA methylation and nucleotide biosynthesis. Excessive alcohol consumption has previously been related to higher colorectal cancer risk (15, 16) , whereas adequate intakes of one-carbon nutrients, including vitamin B-6, vitamin B-12, methionine, and folate, are associated with lower colorectal cancer risk (17, 18) . With consideration of the importance of the epigenetic regulation of IGF2 DMR0 and the potential impact of alcohol on aberrant DNA methylation, we hypothesized that higher alcohol consumption might be associated with higher risk of colorectal cancer with IGF2 DMR0 hypomethylation.
To test this hypothesis, we assessed whether the association of alcohol consumption with colorectal cancer risk differed according to IGF2 DMR0 methylation level in 2 prospective cohort studies in which alcohol intake has been positively associated with risk of colorectal cancer (15, 19, 20) . In secondary analyses, we examined intakes of one-carbon nutrients including vitamin B-6, vitamin B-12, methionine, and folate as exposures.
SUBJECTS AND METHODS

Study population
The Nurses' Health Study (NHS) is a prospective study established in 1976, including 121,701 female nurses aged 30-55 y. The Health Professionals Follow-up Study (HPFS) is a prospective study initiated in 1986, enrolling 51,529 male dentists, optometrists, osteopaths, pharmacists, podiatrists, and veterinarians aged 40-75 y. In this analysis, the baseline year was the first year for which detailed diet information was available. We included participants who provided baseline information on dietary intake in 1980 in the NHS and 1986 in the HPFS. We excluded participants with a history of cancer (except for nonmelanoma skin cancer), inflammatory bowel disease, or familial polyposis at baseline. This study was approved by Human Subjects Committees at Harvard School of Public Health and Brigham and Women's Hospital.
Assessment of dietary intake and other covariates
Alcohol consumption and dietary intakes of vitamin B-6, vitamin B-12, folate, and methionine were assessed with a selfadministered questionnaire by using semiquantitative foodfrequency questionnaires beginning from the baseline year of this analysis (21) . As described in previous studies of these cohorts, we used baseline information of alcohol and one-carbon nutrient intakes for this analysis to take into account the long induction period of colorectal tumor in relation to alcohol and one-carbon nutrient intakes (21, 22) . We assumed an ethanol content of 13.1 g for a 12-oz (38-dL) can or bottle of beer, 11.0 g for a 4-oz (12-dL) glass of wine, and 14.0 g for a standard portion of spirits (21) . We computed nutrient intake by multiplying the consumption frequency of each unit of food by the nutrient content of the specified portions by using composition values from USDA sources (15, 23) . In our analyses, we included any nutrient intake including from supplements to calculate daily intake of each nutrient. This method of dietary assessment was extensively validated by 1-wk diet records conducted in both cohorts (22, 24, 25) . We categorized alcohol consumption into 3 fixed categories (none, 1-14 g/d, and $15 g/d) and folate intake into 4 fixed categories (,200, 200-299, 300-399, and $400 mg/d). All other one-carbon nutrients were categorized into quintiles. Information on lifestyle factors, including weight, smoking status, endoscopy status, regular aspirin use, and postmenopausal hormone use (only for women), were assessed every 2 y from questionnaires in both cohorts.
Assessment of colorectal cancer cases
Incident colorectal cancer cases were ascertained by using a biennial questionnaire, the National Death Index, and a medical record review. Study physicians, who were unaware of the exposure information, reviewed medical and pathologic records to retrieve information on tumor location and disease stage. The International Classification of Diseases (Ninth Edition) codes for colon and rectal cancers are 153 and154, respectively. A total of 3031 colorectal cancer cases were identified through 1 July 2008. We collected available tumor specimens from pathology laboratories across the United States, and data on IGF2 DMR0 methylation analysis were obtained in 993 cases. As described previously, baseline characteristics of participants with colorectal cancer with available tissue molecular data were similar to those of participants without available molecular data (26) . A single pathologist (SO) reviewed tumor tissue slides, and recorded pathologic features.
Pyrosequencing of IGF2 DMR0 methylation
We measured methylation at IGF2 DMR0 by using a previously described bisulfite-pyrosequencing assay (GenBank nucleotides 631-859, accession no. Y13633) (9) . We categorized IGF2 DMR0 methylation levels into quartiles.
Statistical analysis
We followed participants from the date of return of the baseline questionnaire through 1 July 2008. Participants whose IGF2 DMR0 methylation level in tumor was unknown (n = 2038) and those who died of causes other than colorectal cancer (n = 21,970) were censored during 28 y of follow-up. To examine differential associations of baseline alcohol consumption with colorectal cancer risk by IGF2 DMR0 methylation level, we used Cox proportional cause-specific hazards regression models with a duplication method for competing risk data (27, 28) , which is also called a joint Cox proportional (29) . This method accommodates different baseline hazard functions of each disease subtype and permits the estimation of separate associations of a risk factor (e.g., alcohol consumption) with each tumor subtype and has been used to assess whether a risk factor has statistically different regression coefficients for different tumor subtypes (21, 30, 31) . In the incidence analysis of one subtype, incidences of other tumor subtypes or tumor of unknown subtype were treated as censored data. A trend test across exposure categories was performed by assigning the median value to each category and treating these variables as continuous terms in the model. With the use of a random effects meta-regression analysis (32), we assessed whether the magnitude of the exposuresubtype association had an increasing or decreasing ordinal trend across quartiles of tumor IGF2 DMR0 methylation level, and the statistical significance of this trend was presented as P-heterogeneity. Cox model analyses were based on the counting process data structure (33) and were stratified by age (in mo), sex (in the combined cohort analysis), and calendar year of the questionnaire cycle. In multivariable Cox model analyses, we further adjusted for BMI, a family history of colorectal cancer in any first-degree relative, pack-years smoked, lower endoscopy status, regular aspirin use, postmenopausal hormone use (for women only), leisure-time physical activity, number of servings of red meat consumed per day, total caloric intake, calcium intake, current multivitamin use, and each of the other nutrients under evaluation (i.e., intakes of alcohol, vitamin B-6, vitamin B-12, folate, and methionine). With the exception of alcohol, vitamin B-6, vitamin B-12, folate, and methionine, for which we used baseline information, we used the mostupdated available information for covariates before each 2-y follow-up period. We did not observe evidence of a violation of the proportional hazard assumption on the basis of interaction terms between alcohol consumption and follow-up time (P . 0.5).
We used SAS software (version 9.3; SAS Institute) for all statistical analyses. All P values were 2 sided. Because multiple hypothesis testing is inherent to subgroup analyses in molecular pathologic epidemiology (34), we set a heterogeneity test between colorectal cancer subtypes according to IGF2 DMR0 methylation level in relation to alcohol consumption as our primary hypothesis testing in which a P value for significance was set as 0.05. In the primary analysis, median intake within each of alcohol intake categories was used and tested for a statistical trend. All other analyses, including the evaluation of individual HR estimates for alcohol, and analyses of other exposures were secondary analyses, and any positive finding was to be interpreted cautiously, given multiple hypothesis testing. No analysis in this study was planned when cohort studies began, and all analyses were post hoc by definition.
RESULTS
Alcohol consumption and colorectal cancer risk by IGF2 DMR0 methylation level
At baseline, there were 87,805 women in the NHS and 45,770 men in the HPFS. Table 1 shows baseline characteristics of all participants according to the amount of alcohol consumption. During 3,206,985 person-years of follow-up, we identified 993 colorectal cancer cases with available data for IGF2 DMR0 methylation level. Before pooling data from the NHS and HPFS, we conducted heterogeneity tests based on the Q statistic. We did not observe significant heterogeneity between cohorts for the association of alcohol consumption with risk of any specific cancer subtypes (P . 0.2 for Cochran's Q test) (Supplemental Table S1 ). Thus, the NHS and HPFS were combined to increase the statistical power.
As previously described (15, 19, 20) , compared with no alcohol consumption, higher alcohol consumption at baseline was associated with higher risk of overall colorectal cancer [multivariableadjusted HR: 1.28 (95% CI: 1.05, 1.55) for consumption of $15 g alcohol/d; P-trend = 0.043 across alcohol intake categories] ( Table 2 ). Higher alcohol consumption was significantly associated with higher risk of colorectal cancer with first and second quartiles of IGF2 DMR0 methylation [comparing consumption of $15 g alcohol/d to no consumption; multivariable-adjusted HRs: 1.55 (95% CI: 1.08, 2.24; P-trend = 0.009) and 2.11 (95% CI: 1.44, 3.07; P-trend = 0.0004), respectively]. In contrast, alcohol consumption was not associated with risk of colorectal cancer with third and fourth quartiles of IGF2 DMR0 methylation (P-trend $ 0.15; P-heterogeneity = 0.006 across IGF2 DMR0 methylation quartiles).
In sensitivity analyses, we used covariates measured at baseline and examined the association between baseline alcohol consumption and colorectal cancer incidence. Compared with no alcohol consumption, multivariable-adjusted HRs in the $15 g alcohol/d category were 1.44 (95% CI: 1.00, 2.07; P-trend = 0.027) and 1.89 (95% CI: 1.29, 2.77; P-trend = 0.002) for cancer with first and second quartiles of IGF2 DMR0 methylation, respectively, whereas multivariate HRs were 1.13 (95% CI: 0.79, 1.63); P-trend = 0.27; and 0.82 (95% CI: 0.55, 1.23); P-trend = 0.21; for cancer with third and fourth quartiles of IGF2 DMR0 methylation, respectively (P-heterogeneity = 0.012). In addition, we used the most-updated information for all the variables including alcohol, one-carbon nutrients, and other covariates measured before each 2-y follow-up and modeled these variables as time-varying variables. In the sensitivity analysis, results were also consistent with those in our main analysis; the consumption of $15 g alcohol/d was significantly associated with cancer with first and second quartiles of IGF2 DMR0 methylation [multivariable-adjusted HRs: 1.86 (95% CI: 1.25, 2.77; P-trend , 0.0001) and 2.06 (95% CI: 1.36, 3.13; P-trend = 0.0001), respectively], whereas higher alcohol consumption was not significantly associated with cancer with third and fourth quartiles of IGF2 DMR0 methylation [multivariableadjusted HRs: 0.99 (95% CI: 0.66, 1.49; P-trend = 0.63) and 0.95 (95% CI: 0.62, 1.45; P-trend = 0.72), respectively; P-heterogeneity = 0.0008).
One-carbon nutrients and colorectal cancer risk by IGF2 DMR0 methylation level
In secondary analyses, we examined the relation of one-carbon nutrient intakes with colorectal cancer risk according to IGF2 DMR0 methylation level. In Supplemental Tables S2 and S3 , we show sex-specific results for the analysis of vitamin B-6, vitamin B-12, methionine, and folate. In both cohorts combined, we did not observe prominent differential associations between one-carbon nutrient intakes and colorectal cancer incidence by IGF2 DMR0 methylation status ( Table 3) . Although the test for heterogeneity was significant in our methionine analyses (P-heterogeneity = 0.007), none of the tests for trend across 
Family history of CRC, % Values were standardized to the age distribution of the study population. Alcohol and one-carbon nutrient intakes were assessed at baseline, and the most-updated information was used for other covariates in our main analysis. CRC, colorectal cancer; HPFS, Health Professionals Follow-up Study; MET-h, metabolic equivalent task-hours; NHS, Nurses' Health Study. 2 Value is not age adjusted. methionine quintiles were significant (P-trend . 0.09), and HRs did not consistently show a significant risk elevation with increasing levels of methionine intake. In sensitivity analyses, in which we used covariates measured at baseline, tests for trend across quintiles of baseline intakes of vitamin B-6, vitamin B-12, and folate were not significant in any levels of IGF2 DMR0 methylation (P-trend . 0.11). Tests for heterogeneity were also not significant in analyses of vitamin B-6, vitamin B-12, and folate (P-heterogeneity . 0.18). We observe lower risk of colorectal cancer with the fourth quintile of IGF2 DMR0 methylation with increasing baseline intake of methionine (P-trend = 0.0008; P-heterogeneity = 0.010). When we used the most-updated information for all variables, all trend tests across quintiles of vitamin B-6, vitamin B-12, methionine, and folate were not significant (P-trend . 0.075).
DISCUSSION
In 2 large, prospective cohort studies, we showed that excess alcohol consumption was associated with higher risk of colorectal cancer with IGF2 DMR0 hypomethylation and lower levels of IGF2 DMR0 methylation but not risk of colorectal cancer with higher levels IGF2 DMR0 methylation. The association of alcohol intake with colorectal cancer risk significantly differed according to tumor IGF2 DMR0 methylation level. Within the IGF2 DMR0 hypomethylated subtype, the elevation in risk appeared to follow a linear dose-response with increasing risks associated with increasing levels of alcohol intakes. Overall, our data support a possible mechanistic link between alcohol intake and colorectal cancer risk through IGF2 DMR0 hypomethylation during colorectal carcinogenesis. In our secondary analysis, we did not show prominent differential associations of vitamin B-6, vitamin B-12, methionine, and folate intakes with risk of colorectal cancer according to IGF2 DMR0 methylation level.
Tumor molecular analyses of colorectal cancer are increasingly important in clinical and epidemiologic research (35) (36) (37) (38) . Previous studies assessed the relation of alcohol and one-carbon nutrients with changes in various molecular features, including CpG island methylation and TP53 expression status, in colorectal cancer (39) (40) (41) (42) . A previous study also indicated that high alcohol consumption was associated with higher risk of colon cancer with hypomethylation in long interspersed nucleotide element-1, which is an indicator of global DNA methylation 1 Cox proportional cause-specific hazards regression for competing risk data were used to compute HRs and 95% CIs. 2 Linear trend test by using the median value of each category. 3 Test for the heterogeneity of the association between alcohol intake and colorectal cancer risk according to IGF2 DMR0 methylation level.
TABLE 3
Baseline one-carbon nutrient intake and risk of colorectal cancer according to IGF2 DMR0 methylation level (21) . However, to our knowledge, no previous epidemiology study assessed the influence of alcohol and one-carbon nutrients on colorectal cancer risk according to tumor IGF2 DMR0 methylation level. Alcohol has been implicated in colorectal cancer initiation possibly through the inhibition of one-carbon metabolism as well as the action of acetaldehyde (43) . Excess alcohol has been reported to antagonize methyl donors including vitamin B-6, vitamin B-12, methionine, and folate, leading to a lower concentration of S-adenosylmethionine in the liver (43) (44) (45) . In both human and animal studies, a reduction of S-adenosylmethionine concurrently increased S-adenosylhomocysteine and homocysteine concentrations in the plasma (46, 47) , resulting in a lower methylation capacity and hypomethylation in various tissues including the colonic mucosa (48) (49) (50) . The IGF2 gene is maternally imprinted and expressed only from the paternal allele. IGF2 controls cell development, growth, and proliferation, and LOI of IGF2 has been implicated in colorectal cancer (6, 7) and various other cancers (51) . Previous studies reported that IGF2 expression is controlled by DMRs, which are close to the IGF2 promoter (6, 7, (52) (53) (54) . Particularly, the hypomethylation of IGF2 DMR0 can be a surrogate marker of LOI of IGF2 in colorectal cancer (8, 14) . IGF2 upregulation by DMR0 hypomethylation may promote tumorigenesis in colorectal tissue. Taken together, besides the reported global DNA hypomethylation, our findings suggest that excess alcohol consumption might cause DNA hypomethylation at IGF2 DMR0, leading to the epigenetic dysregulation of IGF2 activity and colorectal carcinogenesis. To our knowledge, our study provides new information about the role of excess alcohol consumption in transcriptional control through aberrant local DNA methylation changes. Our study had several important strengths. First, because of the availability of detailed, updated information on several dietary and lifestyle covariates relevant to colorectal cancer over 28 y of follow-up, we were able to examine long-term exposures to alcohol and one-carbon nutrients and take into consideration important confounding factors. Second, because of the prospective nature of our study, differential recall bias, particularly with regard to our dietary assessments, was not of concern. Third, our molecular characterization of colorectal cancer enabled us to conduct molecular pathologic epidemiology research (34, 55) , which could link the risk factor (alcohol) to a molecular signature of disease (IGF2 DMR0 hypomethylation) and, hence, give us unique insights on pathogenic mechanisms and causal inference.
Limitations of note related to the relatively low alcohol consumption in our cohorts of health professionals. We also acknowledge that we could not completely exclude a possibility of residual and unmeasured confounding. In addition, we were unable to obtain tumor tissue from all cases of confirmed colorectal cancer in the 2 cohorts. Nonetheless, risk factors in cases unavailable for tissue analysis did not significantly differ from those in cases with tumor tissue available (31) . We believe that the generalizability of our findings needs to be assessed by independent studies.
In conclusion, we showed that the association of higher alcohol consumption with colorectal cancer risk varies by tumor IGF2 DMR0 methylation level and is stronger for tumor with IGF2 DMR0 hypomethylation. Taken together with previous data, these results suggest that alcohol consumption may increase risk of a potentially more aggressive type of colorectal tumor Linear trend test by using the median value of each category. 3 The test for the heterogeneity of the association between one-carbon nutrient intake and colorectal cancer risk according to IGF2 DMR0 methylation level.
because of the poorer prognosis in colorectal cancer patients with IGF2 DMR0 hypomethylation (9) . Hypomethylation of IGF2 DMR0 may be one mechanism by which alcohol consumption affects colorectal cancer risk. Additional studies are needed to further elucidate genetic and epigenetic alterations attributable to excess alcohol consumption.
